Astrana Health (ASTH) Gross Margin (2010 - 2026)

Astrana Health (ASTH) has 17 years of Gross Margin data on file, last reported at 10.96% in Q1 2026.

• Quarterly Gross Margin fell 54.0% year-over-year to 10.96% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.66% (down 128.0% YoY) and the FY2025 annual result came in at 10.73%, down 261.0% from the prior year.
• Gross Margin grew to 10.96% in Q1 2026 per ASTH's latest filing, from 10.0% in the prior quarter.
• The five-year high for Gross Margin was 24.05% in Q3 2022, with the low at 7.59% in Q4 2024.
• Average Gross Margin over 5 years is 14.22%, with a median of 14.19% recorded in 2023.
• Year-over-year, Gross Margin slumped 1102 bps in 2022 and surged 410 bps in 2024.
• Astrana Health's Gross Margin stood at 13.97% in 2022, then fell by 21 bps to 11.04% in 2023, then sank by 31 bps to 7.59% in 2024, then surged by 32 bps to 10.0% in 2025, then climbed by 10 bps to 10.96% in 2026.
• Business Quant data shows ASTH's Gross Margin at 10.96% in Q1 2026, 10.0% in Q4 2025, and 10.17% in Q3 2025.